Cost-effective cytomegalovirus native antigen
The Native Antigen Company (NAC) has released a highly purified cytomegalovirus (CMV) native antigen, which has been manufactured in response to the in vitro diagnostics (IVD) industry’s requirement for a cost-effective antigen that can demonstrate a high affinity for IgG and IgM. This latest antigen from NAC’s rapidly increasing portfolio also minimises cross-reactivity and lot-to-lot variation.
Your partner for equipment and consumables for medicine and science
Sarstedt, one of the world's leading providers of laboratory and medical equipment, develops, manufactures and sells equipment and consumables in the field of medicine and science.
Founded in 1961, the company has continued to grow to the point where it now employs a...
Manchester Central, Manchester, M2 3GX
22-23 September, 2026
Technology and Innovation Centre, University of Strathclyde, 99 George Street, Glasgow, G1 1RD
24-25 September, 2026
Hilton Antwerp Old Town, Antwerp
4-7 October, 2026
Online
6-7 October, 2026
The Haylofts, St Thomas Street, Haymarket, Newcastle, NE1 4LE, UK
8 October, 2026
